Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

Author： Heldin Carl-Henrik  

Publisher： Springer Publishing Company

ISSN： 1557-1890

Source： Journal of Neuroimmune Pharmacology, Vol.9, Iss.2, 2014-03, pp. : 69-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 217-235

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Notch signaling pathway in autoimmune diseases

By Ma Daoxin   Zhu Yuanchao   Ji Chunyan   Hou Ming  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 553-565

Informa Healthcare

Access to resources Recommend Favorite

Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting -Secretase as an Alternative Drug Target for Treatment of Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 14, Iss. 27, 2007-11 ,pp. : 2848-2864

Bentham Science Publishers

Access to resources Recommend Favorite

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders

By Pathak Swati   Roth Michael   Verma Amit   Steidl Ulrich  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1667-1675

Informa Healthcare

Access to resources Recommend Favorite

Targeting PDGF pathway in pulmonary arterial hypertension

By Antoniu Sabina Antonela  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1055-1063

Informa Healthcare

Access to resources Recommend Favorite